PSMA PET Staging is Advised for All High-Risk Patients With Localized Prostate Cancer

被引:0
|
作者
Murphy, Declan G. [1 ,2 ]
Emmett, Louise [3 ]
机构
[1] Peter MacCallum Canc Ctr, Div Canc Surg, Melbourne, Vic, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia
[3] St Vincents Hosp, Dept Theranost & Nucl Med, Sydney, NSW, Australia
关键词
D O I
10.1016/j.ijrobp.2024.06.031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3
引用
收藏
页码:642 / 645
页数:4
相关论文
共 50 条
  • [1] High Accuracy of PSMA PET in Initial Staging of High-Risk Prostate Cancer
    Waller, Joseph
    Flavell, Robert
    Heath, Courtney Lawhn
    RADIOLOGY-IMAGING CANCER, 2020, 2 (04):
  • [2] Ga 68 PSMA PET/CT at the initial staging of high-risk patients with prostate cancer
    Pipikos, T.
    Vogiatzis, M.
    Andreou, J.
    Kechagias, D.
    Fillipi, V.
    Oikonomou, E.
    Gogos, K.
    Merisoglou, S.
    Papoutsani, D.
    Dalianis, K.
    Efthimiadou, R.
    Prassopoulos, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S453 - S454
  • [3] PSMA PET/CT imaging for primary staging of intermediate and high-risk prostate cancer
    Cook, Gary J. R.
    Kulkarni, Meghana
    Warbey, Victoria S.
    BJU INTERNATIONAL, 2019, 124 (03) : 357 - 358
  • [4] Decision impact study on the use of PET-PSMA for the initial staging of men with high-risk localized prostate cancer (PCa)
    Viaouet, A.
    Verrier, C.
    Mengue, S.
    Leroux, S.
    Desrez, G.
    Haaser, T.
    Herve, R.
    Couturier, O.
    Gustin, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S508 - S508
  • [5] National Uruguayan Experience with PSMA PET/CT in Initial Staging in High-risk prostate cancer
    dos Santos, Gerardo
    Banchero, Agustina
    Quagliata, Adriana
    Niell, Nicolas
    Cordero, Ismael
    Giglio, Javier
    Trindade, Victoria
    Leiva, Juan
    Rodriguez, Sergio
    Sanchez, Aldo
    Savio, Eduardo
    Duarte, Pablo
    Gambini, Juan
    Alonso, Omar
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [6] Immunohistochemical PSMA Expression and Histology Predictors in Primary Staging High-risk Prostate Cancer Patients Studied with PSMA PET/CT: a PSMA Expression Investigation
    Vetrone, L.
    Mei, R.
    Farolfi, A.
    Bianchi, L.
    Giunchi, F.
    De Giovanni, A.
    Calderoni, L.
    Serani, F.
    Costa, F.
    Pissavini, A.
    Schiavina, R.
    Brunocilla, E.
    Castellucci, P.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S403 - S404
  • [7] 68Ga-PSMA and High-Risk Prostate Cancer Staging
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (03) : 19N - 19N
  • [8] PREDICTIVE VALUE OF PSMA PET/CT IMAGING FOR PRIMARY STAGING OF INTERMEDIATE AND HIGH-RISK PROSTATE CANCER
    Campobasso, Davide
    Guarino, Giulio
    Scarlattei, Maura
    Ziglioli, Francesco
    Ferretti, Stefania
    Dinale, Francesco
    Badari, Giorgio
    Gasparro, Donatello
    Ruffini, Livia
    Maestroni, Umberto Vittorio
    ANTICANCER RESEARCH, 2021, 41 (10) : 5277 - 5278
  • [9] Accuracy of PET-choline in nodal staging of localized very high-risk prostate cancer
    Dias, Nuno
    Colandrea, Gianmarco
    Botelho, Francisco
    Rodriguez-Sanchez, Lara
    Barbe, Yann
    Macek, Petr
    Cathelineau, Xavier
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2022, 94 (04) : 401 - 405
  • [10] Ga 68 PSMA PET/CT at the initial staging of high risk patients with prostate cancer
    Prassopoulos, V.
    Pipikos, T.
    Kechagias, D.
    Filippi, V.
    Vlachou, F.
    Andreou, J.
    Dalianis, K.
    Efthymiadou, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S598 - S599